Artiva biotherapeutics reports third quarter 2024 financial results and recent business highlights

Expanded board of directors with appointment of dr. alison moore bringing cell therapy and manufacturing expertise to advance allonk® in autoimmune diseases

ARTV Ratings Summary

ARTV Quant Ranking